The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear¥80.63Fair value¥717.51Bull¥1,327.80
FairClose
52-week traded range
52W low ¥349.0052W high ¥512.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
GENETEC CORPORATION closed at ¥402.00, 44.0% below the consensus fair value of ¥717.51 drawn from 9 valuation models.
Financial DNA score 74/100 — Strong. P/E of 9.1x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
¥80.63
-79.9%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
¥485.27
+20.7%
√(22.5 × EPS × BVPS)
EPS=44.26, BVPS=236.47
P/E Fair Value
¥885.20
+120.2%
EPS × 20x (sector P/E)
EPS=44.26, Sector P/E=20x
Peter Lynch (PEG)
¥1,327.80
+230.3%
EPS × Growth% (PEG = 1 is fair)
EPS=44.26, g=30%
EV/EBITDA
¥1,262.77
+214.1%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=909.87M
Dividend Discount (DDM)
¥1,187.43
+195.4%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=21.99, r=10%, g=8%
Book Value (P/B)
¥821.74
+104.4%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=236.47, ROE=19.9%, g=6%, r=10%
Reverse DCF
¥402.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -3.7% | Historical: 73.3%
Margin of Safety
¥362.78
-9.8%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=483.7, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.